Evidence map›Paper›PMID 25046383›Full record

ArticleJournal of molecular biology2014

Dynactin 3D structure: implications for assembly and dynein binding.

Hiroshi Imai, Akihiro Narita, Yuichiro Maéda, Trina A Schroer

Abstract read
In one paragraph

Article in Journal of molecular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Cytoplasmic dynein and early endosome transport.Cellular and molecular life sciences : CMLS · 2015
    Review
  4. Dynactin revealed.Nature structural & molecular biology · 2015
    Article
  5. Article
  6. Article
  7. Mechanism and regulation of cytoplasmic dynein.Annual review of cell and developmental biology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Hiroshi ImaiERATO Actin Filament Dynamics Project, Japan Science and Technology Agency, c/o RIKEN, Sayo, Hyogo 679-5148, Japan; Laboratory for Structural Biochemistry, RIKEN Harima Institute SPring-8 Center, Sayo, Hyogo 679-5148, Japan.
Akihiro NaritaERATO Actin Filament Dynamics Project, Japan Science and Technology Agency, c/o RIKEN, Sayo, Hyogo 679-5148, Japan; Laboratory for Structural Biochemistry, RIKEN Harima Institute SPring-8 Center, Sayo, Hyogo 679-5148, Japan; Structural Biology Research Center and Division of Biological Sciences, Graduate School of Science, Nagoya University, Furo-cho, Nagoya 464-8601, Japan; JST PRESTO, Japan.
Yuichiro MaédaERATO Actin Filament Dynamics Project, Japan Science and Technology Agency, c/o RIKEN, Sayo, Hyogo 679-5148, Japan; Laboratory for Structural Biochemistry, RIKEN Harima Institute SPring-8 Center, Sayo, Hyogo 679-5148, Japan; Structural Biology Research Center and Division of Biological Sciences, Graduate School of Science, Nagoya University, Furo-cho, Nagoya 464-8601, Japan.
Trina A SchroerDepartment of Biology, Johns Hopkins University, Baltimore, MD 21218, USA. Electronic address: schroer@jhu.edu.
Nagoya University · JPJapan Science and Technology Agency · JPJohns Hopkins University · US

Funding

REGULATION OF CYTOPLASMIC DYNEIN-BASED VESICLE TRANSPORTR01GM044589 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI SCHROER, TRINA A · 1990 to 2012
$4.3M
Regulation of Cytoplasmic Dynein Based Vesicle TransportR56GM044589 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI SCHROER, TRINA A · 2008 to 2008
$410k
Biotechnology and Biological Sciences Research Council BB/K000705/1NIGMS NIH HHS R01 GM044589NIGMS NIH HHS R56 GM044589
6 · The paper itself

Abstract

The multisubunit protein complex, dynactin, is an essential component of the cytoplasmic dynein motor. High-resolution structural work on dynactin and the dynein/dynactin supercomplex has been limited to small subunits and recombinant fragments that do not report fully on either ≈1MDa assembly. In the present study, we used negative-stain electron microscopy and image analysis based on random conical tilt reconstruction to obtain a three-dimensional (3D) structure of native vertebrate dynactin. The 35-nm-long dynactin molecule has a V-shaped shoulder at one end and a flattened tip at the other end, both offset relative to the long axis of the actin-related protein (Arp) backbone. The shoulder projects dramatically away from the Arp filament core in a way that cannot be appreciated in two-dimensional images, which has implications for the mechanism of dynein binding. The 3D structure allows the helical parameters of the entire Arp filament core, which includes the actin capping protein, CP, to be determined for the first time. This structure exhibits near identity to F-actin and can be well fitted into the dynactin envelope. Molecular fitting of modeled CP-Arp polymers into the envelope shows that the filament contains between 7 and 9 Arp protomers and is capped at both ends. In the 7 Arp model, which agrees best with measured Arp stoichiometry and other structural information, actin capping protein (CP) is not present at the distal tip of the structure, unlike what is seen in the other models. The 3D structure suggests a mechanism for dynactin assembly and length specification.

Indexed as

Actin Capping ProteinsActin CytoskeletonAmino Acid SequenceAnimalsBrainChick EmbryoDynactin ComplexDyneinsImage Processing, Computer-AssistedImaging, Three-DimensionalMicrofilament ProteinsMicroscopy, ElectronMicrotubule-Associated ProteinsModels, MolecularProtein BindingActin Capping ProteinsDynactin ComplexDyneinsMicrofilament ProteinsMicrotubule-Associated Proteins3D EMactindyneinmicrotubulesingle particle analysis

Identifiers

PMID25046383
PMCPMC4216434
OpenAlexW1993747463

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.